Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05276739
Other study ID # 2021P000757
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date July 29, 2022
Est. completion date September 30, 2025

Study information

Verified date June 2023
Source Brigham and Women's Hospital
Contact Shadab A Rahman, PhD, MPH
Phone 6175258830
Email sarahman@rics.bwh.harvard.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to determine the principal time cue (light or meals) for resetting circadian rhythms in melatonin and metabolic outcomes.


Description:

The objective of this proposal is to construct and compare PRCs describing the relationship between the timing of light exposure and meals across the 24-hour day and the size and direction of shift in circadian rhythms of circulating lipids and melatonin in humans. Completion of the work will provide mechanistic insight on the role of photic and non-photic cues mediating entrainment of circadian rhythms in humans besides that of melatonin. In this proposal, we will use the same experimental paradigm that we have successfully used previously to characterize and compare PRCs for shifts in melatonin in response to light exposure of different durations and spectra, and as used in our pilot trials demonstrating a robust PRC of lipid circadian rhythms in response to combined photic and non-photic stimuli across the day. We will achieve our objective using a randomized controlled trial in young healthy adults (n=48, 18-30 years) that systematically manipulates the timing of 6.5-hour bright light exposure and 6.5-hour time restricted eating across the 24-hour circadian cycle to specifically: Aim 1: Determine if light is the primary time cue for resetting melatonin but not lipid circadian rhythms. Hypothesis: The resetting response of circadian rhythms in melatonin but not cholesterol and triglycerides is dependent upon the circadian phase at which a 6.5-hour bright light exposure occurs. Aim 2: Determine if meal timing is the primary time cue for resetting lipid but not melatonin circadian rhythms. Hypothesis: The resetting response of circadian rhythms in cholesterol and triglycerides but not melatonin is dependent upon the circadian phase at which a 6.5-hour time restricted eating occurs. Aim 3 (Exploratory): Evaluate the acute effects of eating across the 24-hour day on circulating lipid levels. Hypothesis: The acute effects of 6.5-hour time restricted eating on circulating cholesterol and triglycerides levels are dependent on the circadian phase at which meals are eaten.


Recruitment information / eligibility

Status Recruiting
Enrollment 48
Est. completion date September 30, 2025
Est. primary completion date March 30, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 30 Years
Eligibility Inclusion Criteria: - Aged between 18-30 years - Healthy (no medical, psychiatric or sleep disorders; - Non-smoking for at least 6 months; - Body Mass Index of >18 or <30 kg/m2; - Able to maintain 8-hour consistent sleep schedule during the study - Able to refrain from caffeine, alcohol, medication and supplements during the study Exclusion Criteria: - History of alcohol or substance abuse; - Positive result on drugs of abuse urine toxicology; - Current or past history of sleep disorders, including but not limited to obstructive sleep apnea, narcolepsy, insomnia, or any significant sleep complaint - Psychiatric disorder, or first degree relative with a psychiatric disorder - Recent acute or chronic medical disorder - Use of drugs or medication (birth control OK) likely to affect sleep, alertness or light sensitivity, as determined by the investigators - Visual disorder, including but not limited to color blindness, or family history of glaucoma - Pregnancy or lactation - Shift work (past 3 years) - Transmeridian travel (2 or more time zones) in the past 3 months - Any other reason as determine by the Principal Investigator

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Bright Light
6.5-hour 10,000 lux light pulse (4100K fluorescent light) centered within the 16-hour wake episode (start 4.75 hour after wake and end 11.25 hour after wake).
Time-restricted eating
6.5-hour restricted meal window (4 meals at 4.75, 6.9, 9.1, 11.25 hours after waking) centered within the 16-hour wake episode.
Dim light
dim light (<3 lux) throughout the 16-hour wake episode
12-h meal window
12-hour restricted meal window (4 meals at 2, 6, 10, and 14 hours after waking) centered within the 16-hour wake episode.

Locations

Country Name City State
United States Brigham and Women's Hospital Boston Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
Brigham and Women's Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Amplitude of Phase Response Curve of melatonin Amplitude of phase response curve of melatonin derived by fitting a sinusoidal regression to the individual phase shift data across ~24 hours 24 hours
Primary Amplitude of Phase Response Curve of triglyceride Amplitude of phase response curve of triglyceride derived by fitting a sinusoidal regression to the individual phase shift data across ~24 hours 24 hours
Primary Amplitude of Phase Response Curve of cholesterol Amplitude of phase response curve of cholesterol derived by fitting a sinusoidal regression to the individual phase shift data across ~24 hours 24 hours
Secondary Area under the curve (AUC) of melatonin AUC of melatonin 6.5 hours during intervention
Secondary Area under the curve (AUC) of triglyceride AUC of triglyceride 6.5 hours during intervention
Secondary Area under the curve (AUC) of cholesterol AUC of cholesterol 6.5 hours during intervention
See also
  Status Clinical Trial Phase
Completed NCT05391438 - Impact of Meal Timing on Glycemic Profile in Latino Adolescents With Obesity N/A
Completed NCT02247076 - Does Meal Timing Affect Energy Expenditure N/A